ERBB2 and triple-negative breast carcinoma: Triple-negative breast cancer (TNBC), devoid of estrogen receptors (Ers), progesterone receptors (PRs), and human epidermal growth factor receptor 2 (HER-2), is the most aggressive subtype with limited treatment options and poor prognosis (2).